What happens if piperacillin-tazobactam is given in the same IV line as an aminoglycoside?

• A. Increases nephrotoxicity risk without interaction
• B. No interaction
• C. Inactivates both agents
• D. Synergistic antibacterial activity

Answer: (C)

The key concept here is IV drug compatibility: certain antibiotics can interact when mixed in the same IV line, altering or reducing their activity. Piperacillin-tazobactam is a penicillin-type antibiotic, and aminoglycosides are a different class with a different mechanism. When they’re combined in the same IV line, chemical interactions can occur in the solution that inactivate the aminoglycoside and also diminish the penicillin’s effectiveness. This mutual inactivation means neither drug works as well as intended, which is why the safest practice is to administer them through separate IV lines or ports with a proper flush between drugs.

This isn’t a scenario of no interaction, and it isn’t typically a case of true synergy where the drugs boost each other’s activity. It’s a compatibility problem that can lead to reduced antibacterial activity, so avoiding co-administration in the same line preserves the potency of both agents.